[1] |
Lu LY, Tang XY, Luo GJ, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome in a Chinese family: a case report and review of literature[J]. World J Clin Cases, 2021,9(22):6393⁃6402. doi: 10.12998/wjcc.v9.i22.6393.
|
[2] |
Lindor NM, Arsenault TM, Solomon H, et al. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome[J]. Mayo Clin Proc, 1997,72(7):611⁃615. doi: 10.1016/S0025⁃6196(11)63565⁃9.
|
[3] |
Wang Y, Wu N, Yu K, et al. Case report: pyogenic arthritis, pyoderma gangrenosum, and acne: a single⁃center experience and literature review[J]. Front Immunol, 2021,12:735851. doi: 10.3389/fimmu.2021.735851.
|
[4] |
Tan J, Zhang T, Hao Z, et al. What can we learn from a tortuous diagnosis and treatment experience for a child with PAPA syndrome? A case report[J]. Indian J Dermatol, 2022,67(1):79⁃84. doi: 10.4103/ijd.ijd_277_21.
|
[5] |
Cugno M, Borghi A, Marzano AV. PAPA, PASH and PAPASH syndromes: pathophysiology, presentation and treatment[J]. Am J Clin Dermatol, 2017,18(4):555⁃562. doi: 10.1007/s40257⁃017⁃0265⁃1.
|
[6] |
Löffler W, Lohse P, Weihmayr T, et al. Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts[J]. Infection, 2017,45(4):395⁃402. doi: 10.1007/s15010⁃017⁃0996⁃1.
|
[7] |
Martinez⁃Rios C, Jariwala MP, Highmore K, et al. Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature[J]. Pediatr Radiol, 2019,49(1):23⁃36. doi: 10.1007/s00247⁃018⁃4246⁃1.
|
[8] |
Caorsi R, Picco P, Buoncompagni A, et al. Osteolytic lesion in PAPA syndrome responding to anti⁃interleukin 1 treatment[J]. J Rheumatol, 2014,41(11):2333⁃2334. doi: 10.3899/jrheum.140060.
|
[9] |
王芳, 颜金花. 化脓性无菌性关节炎、坏疽性脓皮病、痤疮综合征发病机制及诊治相关研究进展[J]. 中华风湿病学杂志, 2020,24(10):709⁃714. doi: 10.3760/cma.j.c141217⁃20200414⁃00154.
|
[10] |
Wang D, Höing S, Patterson HC, et al. Inflammation in mice ectopically expressing human pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome⁃associated PSTPIP1 A230T mutant proteins[J]. J Biol Chem, 2013,288(7):4594⁃4601. doi: 10.1074/jbc.M112.443077.
|
[11] |
Mistry P, Carmona⁃Rivera C, Ombrello AK, et al. Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome[J]. Ann Rheum Dis, 2018,77(12):1825⁃1833. doi: 10.1136/annrheumdis⁃2018⁃213746.
|
[12] |
Demidowich AP, Freeman AF, Kuhns DB, et al. Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne)[J]. Arthritis Rheum, 2012,64(6):2022⁃2027. doi: 10.1002/art.34332.
|
[13] |
Lindwall E, Singla S, Davis WE, et al. Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome[J]. Semin Arthritis Rheum, 2015,45(1):91⁃93. doi: 10.1016/j.semarthrit.2015.02. 012.
|
[14] |
傅汝倩, 李志辉. 脯氨酸丝氨酸苏氨酸磷酸酶相互作用蛋白1相关自身炎症性疾病[J]. 中华实用儿科临床杂志, 2021,36(17):1354⁃1357. doi: 10.3760/cma.j.cn101070⁃20200324⁃00491.
|
[15] |
Geusau A, Mothes⁃Luksch N, Nahavandi H, et al. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA⁃like syndrome responding to canakinumab treatment[J]. JAMA Dermatol, 2013,149(2):209⁃215. doi: 10.1001/2013.jamadermatol. 717.
|
[16] |
Sood AK, McShane DB, Googe PB, et al. Successful treatment of PAPA syndrome with dual adalimumab and tacrolimus therapy[J]. J Clin Immunol, 2019,39(8):832⁃835. doi: 10.1007/s10875⁃019⁃00685⁃6.
|
[17] |
Sardana K, Bajaj S, Bose SK. Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost⁃effective therapy with a 2⁃year follow⁃up[J]. Clin Exp Dermatol, 2019,44(5):577⁃579. doi: 10.1111/ced.13792.
|
[18] |
Alhumam A. Rare case of pyoderma gangrenosum in the setting of PAPA syndrome in a 12⁃year⁃old child[J]. Int J Low Extrem Wounds, 2021:1395722392. doi: 10.1177/15347346211036023.
|